CLINICAL_TRIALS
trial_result
· 2018-01-12
Clinical Trial Update: Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the Knee [Phase 2]
Summary
Phase 2 study evaluating local duration of exposure from FX006 in patients with osteoarthritis of the knee has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2018-01-12